The company’s FiberHalo^™ stent deployment catheter will enable the physician to deploy the stent and measure in-stent lumen area during the procedure. The FiberHalo^™ post-dilatation catheter will be able to correct for any under-expansion and also measure post-dilatation results.

CorNova is developing the Valecor Platinum^® stent, a bare-metal stent with a pure platinum surface for increased biocompatibility and designed to reduce arterial injury, that has shown superior performance and anti-restenosis properties compared to current bare-metal stents.

CorNova to Present at the Glimpse into the Future: Emerging Drug-Eluting Stents Symposium at EuroPCR 2009 (May 2009)

CorNova, Inc. announces the addition of Andrew T. Jay, D.M.D., M.B.A., to its board of directors (Feb 2009)

CorNova, Inc. announces the expansion of its executive team with the appointment of Robert Gallahue as chief financial officer (Feb 2009)

CorNova, Inc. announces the expansion of its technical team with the appointment of Richard Sahagian as Senior Scientist (Feb 2009)